A phase dose finding trial of the intravenous injection of CV787, a prostate specific antigen-dependent cytolytic adenovirus in patients with advanced hormone refractory prostate cancer (HRPC)
- 1 April 2001
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 37, S217-S218
- https://doi.org/10.1016/s0959-8049(01)81289-2
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: